OPR - Delayed Quote • USD ITCI Aug 2024 50.000 call (ITCI240816C00050000) Follow 29.00 0.00 (0.00%) At close: February 16 at 1:21 PM EST Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for ITCI240816C00050000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: ITCI Will Intra-Cellular Therapies (ITCI) Report Negative Q1 Earnings? What You Should Know Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares 10 Best Performing Biotech ETFs in 2024 Intra-Cellular Therapies Prices Public Offering of Common Stock Biotech Leader Intra-Cellular Soars 23%, Breaks Out Past Latest Buy Point Intra-Cellular (ITCI) Up as Depression Drug Meets Study Goals Intra-Cellular (ITCI) Moves 23.3% Higher: Will This Strength Last? Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock Intra-Cellular Launches 23% To Record High, Breaking Out After Depression Drug Scores Big Intra-Cellular builds case for depression drug with late-stage trial win Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder Intra-Cellular Therapies (NASDAQ:ITCI) advances 6.5% this week, taking five-year gains to 467%
